- CSM Researchers and collaborators discover predictive biomarker for key colorectal cancer drug
- MSc students from the Netherlands visit the CSM
- Our miRNAmeConverter package (https://bit.ly/2fFe5BA) now supports miRBase 22!
- PurinesDX conference April 24th RCSI
- ‘Breast-Predict’ have developed a tool that may predict how effective chemotherapy is likely to be in treating triple-negative breast cancer patients.
- GLIOTRAIN : European Training Network PhD Student Position available
- CoEN Award to CSM-Network of Centres of Excellence in Neurodegeneration
- GLIOTRAIN, Brain Tumor Ireland and RCSI Presents Two Public Lectures- Friday March 9th
- Physiology News Letter 2nd Edition January 2018
- JPND fund the CSM and its partners 1.5M
Author Archives: Helena Bonner
Scientists discover predictive biomarker for key colorectal cancer drug Friday, 01 June 2018: The ANGIOPREDICT research consortium have discovered a potential biomarker that can predict which patients will receive most benefit from a key drug used to treat colorectal cancer (Avastin). … Continue reading
Monday 30th April 34 students and 2 professors from Radboud University Nijmegen (the Netherlands) visited RCSI and the CSM labs. They were welcomed by Prof. Prehn and Dr Helena Bonner and spent the day listening to presentations on the research … Continue reading
Our miRNAmeConverter package (https://bit.ly/2fFe5BA) now supports miRBase 22! (doi:10.1093/bioinformatics/btw660)
The PurinesDX consortium (coordinated by Dr Tobias Engel, RCSI) will be hosting its first meeting on April 24th 2018 at the Cheyne Lecture Theatre – see programme attached! Registration (free) at firstname.lastname@example.org. PurinesDX Mini-symposium 24 April 2018
‘Breast-Predict’ have developed a tool that may predict how effective chemotherapy is likely to be in treating triple-negative breast cancer patients.
Irish scientists raise new hope in fight against aggressive breast cancer Doctors may soon be able to spare some cancer patients the harsh effects of chemotherapy. Researchers from RCSI and the Irish Cancer Society research centre ‘Breast-Predict’ have developed a … Continue reading
Applications are invited from candidates of excellence wishing to pursue a PhD degree in the field of cancer precision medicine. Students will receive training within a pan-European academic/privatesector research training network, specifically focused on brain tumour research. Closing date for … Continue reading
Title of project: Carbon-Model: Carbon metabolism systems analysis for the identification of disease and patient-specific metabolic and energetic defects in neurodegenerative diseases awarded to Prof. Jochen Prehn and Co-applicants: Dr. Niamh Connolly and Dr. Simon Furney, CSM, RCSI and Daniele Bano, … Continue reading
Prof Annette Byrne, GLIOTRAIN Coordinator is taking part in this joint event on 9th March organised by Brain Tumour Ireland and RCSI, as part of Brain Awareness Week 2018. The two lectures are open to the public and are free, … Continue reading
we have put together all of our awards, achievements and social events in our bi-annual news letter: Physiology Newsletter_ Jan 2018_IA_LB_HB
January 2018 The EU Joint Programme – Neurodegenerative Disease Research (JPND) is the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases. JPND supports transnational research projects and working groups that enable researchers to collaborate across borders to … Continue reading